Half-year report · Q2
190A.TEDINET S100VLRA
Period2024-09-01 → 2025-02-28
Filed2025-04-11
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 41
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥996m | 2024-09-01 → 2025-02-28 | Standalone | Operating income |
| Operating income | −¥810m | 2023-09-01 → 2024-02-29 | Standalone | Operating income |
| Ordinary income | −¥975m | 2024-09-01 → 2025-02-28 | Standalone | Ordinary income |
| Ordinary income | −¥1.8bn | 2023-09-01 → 2024-08-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥801m | 2023-09-01 → 2024-02-29 | Standalone | Ordinary income |
| Profit before tax | −¥975m | 2024-09-01 → 2025-02-28 | Standalone | Income before income taxes |
| Profit before tax | −¥801m | 2023-09-01 → 2024-02-29 | Standalone | Income before income taxes |
| Net income | −¥976m | 2024-09-01 → 2025-02-28 | Standalone | Profit loss |
| Net income | −¥1.8bn | 2023-09-01 → 2024-08-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥803m | 2023-09-01 → 2024-02-29 | Standalone | Profit loss |
| Total assets | ¥3.5bn | at 2025-02-28 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2024-08-31 | Standalone | Assets |
| Total assets | ¥3.9bn | at 2024-02-29 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥205m | at 2025-02-28 | Standalone | Liabilities |
| Total liabilities | ¥471m | at 2024-08-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.2bn | at 2025-02-28 | Standalone | Net assets |
| Net assets / equity | ¥4.2bn | at 2024-08-31 | Standalone | Net assets |
| Net assets / equity | ¥3.7bn | at 2024-02-29 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.3bn | at 2025-02-28 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.3bn | at 2024-08-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.3bn | at 2025-02-28 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2024-08-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2024-02-29 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.8bn | at 2023-08-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥1.1bn | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.9bn | 2023-09-01 → 2024-08-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2023-09-01 → 2024-02-29 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥667,000 | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥11m | 2023-09-01 → 2024-08-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥178,000 | 2023-09-01 → 2024-02-29 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥62m | 2024-09-01 → 2025-02-28 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.5bn | 2023-09-01 → 2024-08-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-14.31 | 2024-09-01 → 2025-02-28 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-31.11 | 2023-09-01 → 2024-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.22 | 2023-09-01 → 2024-02-29 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 94.0% | at 2025-02-28 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2024-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.1% | at 2024-02-29 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 68,988,800 | at 2025-02-28 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 67,678,800 | at 2024-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 56,443,800 | at 2024-02-29 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 328
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes paid ope cf | CurrentYTDDuration_NonConsolidatedMember | -2420000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration_NonConsolidatedMember | -1052483000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration_NonConsolidatedMember | -1114470000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration_NonConsolidatedMember | -178000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration_NonConsolidatedMember | -667000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration_NonConsolidatedMember | -178000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration_NonConsolidatedMember | -667000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYTDDuration_NonConsolidatedMember | 61580000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration_NonConsolidatedMember | 61580000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration_NonConsolidatedMember | -1052661000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration_NonConsolidatedMember | -1053557000 | JPY |
| Cash and cash equivalents | Prior2YearInstant_NonConsolidatedMember | 4799035000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 4329624000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant_NonConsolidatedMember | 3746373000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant_NonConsolidatedMember | 3276066000 | JPY |
| Directors compensations sga | Prior1YTDDuration_NonConsolidatedMember | 22500000 | JPY |
| Directors compensations sga | CurrentYTDDuration_NonConsolidatedMember | 22900000 | JPY |
| Payroll and allowances sga | Prior1YTDDuration_NonConsolidatedMember | 28442000 | JPY |
| Payroll and allowances sga | CurrentYTDDuration_NonConsolidatedMember | 28635000 | JPY |
| Depreciation sga | Prior1YTDDuration_NonConsolidatedMember | 462000 | JPY |
| Depreciation sga | CurrentYTDDuration_NonConsolidatedMember | 361000 | JPY |
| Business consignment expenses sga | Prior1YTDDuration_NonConsolidatedMember | 64321000 | JPY |
| Business consignment expenses sga | CurrentYTDDuration_NonConsolidatedMember | 87623000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-04-11 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第８期中（自2024年９月１日 至2025年２月28日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社 | |
| Company name in english cover page | FilingDateInstant | Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 三宅 洋 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)神奈川県藤沢市村岡東二丁目26番地の1 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03-6661-9543 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経営管理部長 佐藤 義彦 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)神奈川県藤沢市村岡東二丁目26番地の1 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-6661-9543 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経営管理部長 佐藤 義彦 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E38905 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 190A0 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)Ｃｈｏｒｄｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社 | |
| Filer name in english | FilingDateInstant | Chordia Therapeutics Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |